The effects of topical nasal steroids on continuous positive airway pressure compliance in patients with obstructive sleep apnea

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200715001

Enrollment

Unknown

Registered

2020-07-15

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuous positive airway pressure (CPAP) for treatment of obstructive sleep apnea can produce troublesome nasal symptoms (i.e. congestion&#44

Interventions

Patients received CPAP and were prescribed to use at home follow up 1&#44

3 months

Experimental Drug,No Intervention No treatment

CPAP with tropical nasal steroid,CPAP without tropical nasal steroid

&#45

OSA Patients received treatment with topical nasal fluticasone furoate 1 spray per nostril hs (55 mcg per day) &#45

Patients received CPAP and were prescribed to use at home and follow up 1&#44

3 months ,&#45

OSA Patients without topical nasal fluticasone furoate &#45

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Patient ranging in age from 18 to 70 years 2. Obstructive sleep apnea patient who were prescribed CPAP treatment by an ENT specialist 3. Patient with at least one nasal symptoms complaint such as rhinorrhea, nasal obstruction, nasal itching, and/or sneezing 4. Patient gave consent to be part of the study

Exclusion criteria

Exclusion criteria: Exclusion criteria 1. Patient refused to use CPAP device as a treatment for OSA 2. Patient refused to use topical nasal steroids 3. Patient had side effect from topical nasal steroids 4. Patient had received topical nasal steroids within 1 month prior to the study 5. Patient had lesion such as nasal septum deviation, nasal polyps, or unusual mass in their nostril 6. Patient had severe medical illness that could affect the treatment 7. Patient had a history of physical or mental abnormality that caused irregular sleep

Design outcomes

Primary

Measure	Time frame
To investigate the effect of topical nasal steroids on continuous positive airway pressure complianc 3 months Compliance Data was collected from CPAP memory card evaluated the continuity of CPAP use including	—

Secondary

Measure	Time frame
To investigate the effect of topical nasal steroids on CPAP to Total nasal score 3 months Survey result from total nasal symptom score included rhinorrhea, nasal itching, nasal obstruction,	—

Countries

Thailand

Contacts

Public ContactRutti Chumthong

Department of otolaryngology Phramongkutkloa hospital

rutti_c@yahoo.com(66)894999773

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026